HighVista Strategies as of Dec. 31, 2021
Portfolio Holdings for HighVista Strategies
HighVista Strategies holds 69 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dell Technologies CL C (DELL) | 15.9 | $20M | 355k | 56.17 | |
| Coupang Cl A (CPNG) | 6.0 | $7.5M | 256k | 29.38 | |
| Xilinx | 4.1 | $5.1M | 24k | 212.01 | |
| Msd Acquisition Corp Unit 03/25/2026 | 4.0 | $5.1M | 500k | 10.16 | |
| Ihs Markit SHS | 3.5 | $4.4M | 33k | 132.91 | |
| Coherent | 2.9 | $3.6M | 14k | 266.54 | |
| Nuance Communications | 2.9 | $3.6M | 65k | 55.32 | |
| People's United Financial | 2.8 | $3.5M | 196k | 17.82 | |
| Cyrusone | 2.8 | $3.5M | 39k | 89.72 | |
| Change Healthcare | 2.8 | $3.5M | 162k | 21.38 | |
| Catalyst Partnrs Acquisitn C Unit 99/99/9999 | 1.6 | $2.0M | 200k | 10.01 | |
| Arena Pharmaceuticals Com New | 1.6 | $2.0M | 21k | 92.94 | |
| Xenon Pharmaceuticals (XENE) | 1.6 | $2.0M | 63k | 31.24 | |
| Argenx Se Sponsored Adr (ARGX) | 1.6 | $1.9M | 5.6k | 350.23 | |
| Merus N V (MRUS) | 1.4 | $1.7M | 54k | 31.80 | |
| Iveric Bio | 1.3 | $1.7M | 101k | 16.72 | |
| Travere Therapeutics (TVTX) | 1.3 | $1.7M | 54k | 31.03 | |
| Aclaris Therapeutics (ACRS) | 1.3 | $1.6M | 112k | 14.54 | |
| Cytokinetics Com New (CYTK) | 1.3 | $1.6M | 35k | 45.58 | |
| Iteos Therapeutics (ITOS) | 1.3 | $1.6M | 35k | 46.57 | |
| Fulcrum Therapeutics (FULC) | 1.3 | $1.6M | 90k | 17.68 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.2 | $1.5M | 53k | 28.41 | |
| Blueprint Medicines (BPMC) | 1.2 | $1.5M | 14k | 107.13 | |
| Gritstone Oncology Ord (GRTS) | 1.2 | $1.5M | 114k | 12.86 | |
| Relay Therapeutics (RLAY) | 1.1 | $1.4M | 46k | 30.70 | |
| Prothena Corp SHS (PRTA) | 1.1 | $1.4M | 28k | 49.40 | |
| Mirati Therapeutics | 1.1 | $1.4M | 9.2k | 146.71 | |
| United Therapeutics Corporation (UTHR) | 1.1 | $1.4M | 6.3k | 216.09 | |
| Fate Therapeutics (FATE) | 1.1 | $1.4M | 23k | 58.49 | |
| Amicus Therapeutics (FOLD) | 1.0 | $1.3M | 113k | 11.55 | |
| Iovance Biotherapeutics (IOVA) | 1.0 | $1.3M | 67k | 19.09 | |
| Horizon Therapeutics Pub L SHS | 1.0 | $1.2M | 11k | 107.72 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $1.2M | 7.1k | 169.60 | |
| Celldex Therapeutics Com New (CLDX) | 0.9 | $1.2M | 30k | 38.65 | |
| Kura Oncology (KURA) | 0.9 | $1.1M | 82k | 14.00 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.9 | $1.1M | 8.5k | 134.53 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $1.1M | 5.1k | 219.67 | |
| Morphic Hldg (MORF) | 0.9 | $1.1M | 24k | 47.37 | |
| Vistagen Therapeutics Com New | 0.9 | $1.1M | 577k | 1.95 | |
| Springworks Therapeutics (SWTX) | 0.9 | $1.1M | 18k | 62.00 | |
| Beam Therapeutics (BEAM) | 0.9 | $1.1M | 14k | 79.70 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $1.1M | 31k | 34.19 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $1.1M | 44k | 23.77 | |
| Natera (NTRA) | 0.8 | $1.0M | 11k | 93.40 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $1.0M | 47k | 21.83 | |
| C4 Therapeutics Com Stk (CCCC) | 0.8 | $1.0M | 32k | 32.20 | |
| Aadi Bioscience (AADI) | 0.8 | $979k | 41k | 24.14 | |
| Instil Bio | 0.8 | $974k | 57k | 17.12 | |
| Regenxbio Inc equity us cm (RGNX) | 0.8 | $973k | 30k | 32.70 | |
| Ideaya Biosciences (IDYA) | 0.8 | $960k | 41k | 23.63 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $919k | 40k | 23.10 | |
| Repare Therapeutics Ord (RPTX) | 0.7 | $917k | 44k | 21.08 | |
| Invesco Db Commdy Indx Trck Unit (DBC) | 0.7 | $881k | 42k | 20.78 | |
| Macrogenics (MGNX) | 0.7 | $867k | 54k | 16.05 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $839k | 38k | 21.88 | |
| Kinnate Biopharma (KNTE) | 0.7 | $820k | 46k | 17.72 | |
| Shattuck Labs (STTK) | 0.6 | $759k | 89k | 8.51 | |
| Beigene Sponsored Adr (BGNE) | 0.6 | $699k | 2.6k | 270.93 | |
| Verve Therapeutics (VERV) | 0.6 | $692k | 19k | 36.84 | |
| Invitae (NVTAQ) | 0.5 | $687k | 45k | 15.28 | |
| Gh Research Ordinary Shares (GHRS) | 0.5 | $630k | 27k | 23.32 | |
| Forma Therapeutics Hldgs SHS | 0.5 | $578k | 41k | 14.23 | |
| Bridgebio Pharma (BBIO) | 0.4 | $565k | 34k | 16.69 | |
| Nurix Therapeutics (NRIX) | 0.4 | $544k | 19k | 28.94 | |
| Olema Pharmaceuticals (OLMA) | 0.4 | $477k | 51k | 9.36 | |
| Adagio Therapeutics (IVVD) | 0.4 | $472k | 65k | 7.25 | |
| Ocular Therapeutix (OCUL) | 0.3 | $411k | 59k | 6.97 | |
| Atea Pharmaceuticals (AVIR) | 0.1 | $185k | 21k | 8.95 | |
| Silverback Therapeutics (SPRY) | 0.1 | $149k | 22k | 6.64 |
